Epidiolex

Evaluating the Therapeutic Potential of Cannabinoids: How to conduct research within the current regulatory framework [VIDEO]

On December 8, 2018, the following NIH-sponsored proceeding took place: “Evaluating the Therapeutic Potential of Cannabinoids: How to conduct research within the current regulatory framework“ From the website: The National Center for Complementary and Integrative Health (NCCIH), at the National Institutes of Health (NIH), sponsored a workshop on December 8,Read More →

CBD-Derived Epidiolex Gains FDA Approval for Epilepsy

In an historic first, the U.S. Food and Drug Administration approved the drug Epidiolex for the treatment of children with epilepsy. The FDA-approved prescription of Epidiolex is specifically intended for the treatment of two kinds of very severe epilepsy, namely: Dravet  syndrome and Lennox-Gastaut Syndrome. GW Pharmaceuticals, based in the UK, manufactures theRead More →